VIDEO: https://www.youtube.com/watch?v=th0uZmXkP0Y NEW YORK, Jan. 20, 2026 /PRNewswire/ -- The World Fertility Awards (WFAs), produced by pregnantish, the first global, consumer-facing media event...
VIDEO: https://www.youtube.com/watch?v=th0uZmXkP0Y NEW YORK, Jan. 20, 2026 /PRNewswire/ -- The World Fertility Awards (WFAs), produced by pregnantish, the first global, consumer-facing media event...
SPOKANE, Wash., Jan. 20, 2026 /PRNewswire/ -- Gestalt, a recognized leader in digital pathology and AI-powered workflow solutions, is proud...
SPOKANE, Wash., Jan. 20, 2026 /PRNewswire/ -- Gestalt, a recognized leader in digital pathology and AI-powered workflow solutions, is proud...
SPOKANE, Wash., Jan. 20, 2026 /PRNewswire/ -- Gestalt, a recognized leader in digital pathology and AI-powered workflow solutions, is proud...
Patent-pending direct-on-vial RFID label enables DSCSA-ready traceability across pharmaceutical manufacturing and hospital workflowsTAICHUNG, Jan. 20, 2026 /PRNewswire/ -- SAG today...
Patent-pending direct-on-vial RFID label enables DSCSA-ready traceability across pharmaceutical manufacturing and hospital workflowsTAICHUNG, Jan. 20, 2026 /PRNewswire/ -- SAG today...
Patent-pending direct-on-vial RFID label enables DSCSA-ready traceability across pharmaceutical manufacturing and hospital workflowsTAICHUNG, Jan. 20, 2026 /PRNewswire/ -- SAG today...
Q4 GAAP sales of $6.1 billion, up 2.1%; operating margin of 13.0%, down 510 bps; EPS of $1.07, down 20%,...
Q4 GAAP sales of $6.1 billion, up 2.1%; operating margin of 13.0%, down 510 bps; EPS of $1.07, down 20%,...
Q4 GAAP sales of $6.1 billion, up 2.1%; operating margin of 13.0%, down 510 bps; EPS of $1.07, down 20%,...
NEW YORK , Jan. 20, 2026 /PRNewswire/ -- The Global Patient Engagement Solutions Market is undergoing a profound transformation as healthcare systems worldwide...
NEW YORK , Jan. 20, 2026 /PRNewswire/ -- The Global Patient Engagement Solutions Market is undergoing a profound transformation as healthcare systems worldwide...
NEW YORK , Jan. 20, 2026 /PRNewswire/ -- The Global Patient Engagement Solutions Market is undergoing a profound transformation as healthcare systems worldwide...
The DROP-FPF trial is the first Phase 3 trial in interstitial lung disease (ILD) to use automated, quantitative high-resolution CT scan...
The DROP-FPF trial is the first Phase 3 trial in interstitial lung disease (ILD) to use automated, quantitative high-resolution CT scan...
The DROP-FPF trial is the first Phase 3 trial in interstitial lung disease (ILD) to use automated, quantitative high-resolution CT scan...
NORTHAMPTON, MA / ACCESS Newswire / January 20, 2026 / Beyond Benign's Green Chemistry Commitment (GCC) has been awarded the...
NORTHAMPTON, MA / ACCESS Newswire / January 20, 2026 / Beyond Benign's Green Chemistry Commitment (GCC) has been awarded the...
NORTHAMPTON, MA / ACCESS Newswire / January 20, 2026 / Beyond Benign's Green Chemistry Commitment (GCC) has been awarded the...